Received Mar 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
flu symptoms for two days; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of flu symptoms in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (had the shingles last summer, it last about 30 day) and pain. In MAR-2025, the patient received Shingrix. In MAR-2025, an unknown time after receiving Shingrix, the patient experienced flu symptoms (Verbatim: flu symptoms for two days). The outcome of the flu symptoms was not resolved. The reporter considered the flu symptoms to be related to Shingrix. The company considered the flu symptoms to be related to Shingrix. Additional Information: GSK receipt date: 07-MAR-2025 This case was reported by a patient via interactive digital media. The patient had the shingles last summer, it was last about 30 days, very painful, trying to sleep at night was uncomfortable. The patient reporter that he just got the first shot four days ago (Day before reporting) and had flu symptoms for two days but it beats the shingles by far.
Medical History/Concurrent Conditions: Pain; Shingles (had the shingles last summer, it last about 30 day)